Manojit Saha And Sohini Das

Stories by Manojit Saha And Sohini Das

How Punjab & Sind Bank plans to boost deposits

How Punjab & Sind Bank plans to boost deposits

Rediff.com   15 Dec 2022

State-owned Punjab & Sind Bank is targeting salary accounts to boost the share of low-cost deposits. Swarup Saha, managing director and chief executive officer of the New Delhi-based lender, tells Manojit Saha that the bank may see gross non-performing assets (NPAs) fall below 8 per cent if there is resolution of the stressed assets.

Pharma, consumer durables sectors likely to feel China curb heat

Pharma, consumer durables sectors likely to feel China curb heat

Rediff.com   12 Dec 2022

The pharmaceutical and the consumer durables sectors, which depend on China for imports, have not been impacted yet due to unrest in China with people protesting against lockdowns. But the lockdown could have an impact on the supply of components used in consumer durables if it continues for the next fortnight. In the pharmaceutical industry, Indian players import 66-70 per cent of their bulk drug requirements from China.

e-Rupee: RBI creates Rs 1.71 crore of digital currency for retail pilot

e-Rupee: RBI creates Rs 1.71 crore of digital currency for retail pilot

Rediff.com   2 Dec 2022

The pilot project for central bank digital currency (CBDC) in the retail segment went live on Thursday with the Reserve Bank of India (RBI) issuing Rs 1.71 crore to four participating banks based on their indents. The central bank has identified four banks for the first phase of the pilot - State Bank of India, ICICI Bank, Yes Bank and IDFC First Bank - in four cities, Mumbai, New Delhi, Bengaluru and Bhubaneswar. The highest indent was received from one private sector bank.

'Inflation will go below 6% in a couple of quarters'

'Inflation will go below 6% in a couple of quarters'

Rediff.com   28 Oct 2022

'We have delivered a bitter medicine. It will take time to work.'

New Covid strains may lead to spike in hospitalisation, fear experts

New Covid strains may lead to spike in hospitalisation, fear experts

Rediff.com   27 Oct 2022

An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.

Why Govt Wants To Ban These Cough Meds

Why Govt Wants To Ban These Cough Meds

Rediff.com   17 Oct 2022

Codeine-based formulations are under the scanner for misuse as a narcotic product.

Now, medical device resellers need to register

Now, medical device resellers need to register

Rediff.com   5 Oct 2022

The Centre has asked traders and resellers of medical devices to register in an attempt to expand the ambit of regulating the medical devices industry in the country. The move can have far-reaching consequences for both consumers and traders alike as products like face masks or prophylactics - now sold through grocers and other channels - may face issues of availability. In a notification dated September 30, the union ministry of health and family welfare said anyone wanting to sell, stock, exhibit or offer for sale or distribute a medical device, including in-vitro diagnostic medical device, will need a certificate of registration.

Sharp Spike In Fever Cases

Sharp Spike In Fever Cases

Rediff.com   1 Oct 2022

'This year there is a sharp spike in fever cases, and it seems to be more than the pre-COVID-19 levels.'

Rupee trade: Two Russian banks get RBI nod for special vostro account

Rupee trade: Two Russian banks get RBI nod for special vostro account

Rediff.com   29 Sep 2022

The Reserve Bank of India (RBI) has given its approval to two Russian banks for opening special vostro account for rupee trade. Sberbank, JSC VTB - the largest and second largest bank of Russia - are the first foreign lenders to receive this approval after the central bank announced the norms on INR trade in July. Both lenders have branch presence in India. Earlier this month, state-run UCO Bank received the RBI's approval to open a special Vostro account with Gazprombank of Russia. While the Kolkata-based lender is in the process of opening the account, the bank has received requests from various foreign lenders for opening such an account.

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Rediff.com   27 Sep 2022

The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).

Banks alert customers about mobile banking malware targeting over 200 apps

Banks alert customers about mobile banking malware targeting over 200 apps

Rediff.com   21 Sep 2022

Several Indian banks have alerted their customers not to download apps from any source other than official app stores. Banking customers are being targeted by a new type of mobile banking malware campaign using SOVA Android Trojan. This malware captures the credentials when users log onto their net-banking apps and access bank accounts. The new version of SOVA appears to be targeting more than 200 mobile applications, including banking apps and crypto wallets.

Moscow now wants biz in ruble, trade may take a hit

Moscow now wants biz in ruble, trade may take a hit

Rediff.com   19 Sep 2022

Russian traders have started asking for payments in ruble for their exports to India in a move that could derail trade between the two countries which gathered pace after the war in Europe. This is because Indian importers are unable to pay in ruble. The India-Russia trade gathered pace after Vladimir Putin invaded Ukraine in February this year. In the April-June quarter, India's imports from Russia were valued at $9.27 billion, up 369 per cent year on year.

Ni-kshay Mitra: Crowdfunding To Fight TB

Ni-kshay Mitra: Crowdfunding To Fight TB

Rediff.com   17 Sep 2022

This would be India's largest crowd-funded programme to help patients with a particular disease.

34 new drugs added to 'essential medicines' list, 26 dropped

34 new drugs added to 'essential medicines' list, 26 dropped

Rediff.com   14 Sep 2022

As many as 34 new drugs were added to and 26 dropped from an updated list of essential medicines on Tuesday, with the government saying this will reduce "patients' out-of-pocket expenditure". The National List of Essential Medicines (NLEM 2022) has 384 drugs, up from 376 in 2015. "Drafting this list is a lengthy process, and around 350 experts from across India have held over 140 consultation meetings to draft the NLEM 2022," Union Health Minister Mansukh Mandaviya said.

Another 35-50 bps repo rate hike on cards

Another 35-50 bps repo rate hike on cards

Rediff.com   14 Sep 2022

With retail inflation surprising on the upside, the six-member monetary policy committee (MPC) of the Reserve Bank of India (RBI) is expected to increase the repo rate by 35-50 basis points (bps) in the review scheduled for September 28-30. According to economists, the central bank will continue to focus on bringing inflation down even though economic growth has remained sluggish. Data released by the government on Monday showed that the consumer price index (CPI)-based inflation increased by 7 per cent year-on-year (YoY) in August, thus, staying above the upper tolerance limit of the central bank for all the eight months of 2022.

Coming Soon, New Ways To Vaccinate

Coming Soon, New Ways To Vaccinate

Rediff.com   3 Sep 2022

'Just put a patch on your arm and the vaccine can be absorbed by the body.'

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com   22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com   17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

'Around 100 million doses will definitely be wasted'

'Around 100 million doses will definitely be wasted'

Rediff.com   13 Aug 2022

'We are trying to salvage 50-100 million doses of Covishield with the latest drive on booster doses.'

HDFC Bank's Kaizad Bharucha took home the most among bankers in FY22

HDFC Bank's Kaizad Bharucha took home the most among bankers in FY22

Rediff.com   10 Aug 2022

Kaizad Bharucha, executive director of HDFC Bank, emerged the highest earning banker for 2021-22 (FY22). This was revealed in a remuneration assessment of the country's top bankers, according to annual reports. Bharucha, who oversees wholesale banking at HDFC Bank, received Rs 10.64 crore remuneration in FY22, mainly due to Rs 4.46 crore as performance bonus. Although earned between 2017-18 and 2020-21 (FY21), the bonus payout was partly paid in FY22.